VcR-CVAD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VcR-CVAD, covering 2011-02-15 to 2011-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma [Phase 2]